Moderna and Rovi to collaborate for manufacturing of Moderna's COVID-19 vaccine candidate.

Global Banking News-July 10, 2020-Moderna and Rovi to collaborate for manufacturing of Moderna's COVID-19 vaccine candidate

(C)2020 ENPublishing - http://www.enpublishing.co.uk

Moderna Inc (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines, and Laboratorios Farmaceuticos Rovi SA (Rovi)(BME: ROVI), a pan-European pharmaceutical company specialising and engaging in the research, development, contract manufacturing and marketing of small molecules and biological specialties, announced on Thursday a collaboration for large-scale, commercial fill-finish manufacturing of Moderna's mRNA vaccine candidate against COVID-19 (mRNA-1273) at Rovi's facility in Madrid, Spain.

As a part of the agreement, Rovi will provide vial filling and packaging capacity by procuring a new production line and equipment for compounding, filling, automatic visual inspection and labelling to support production of hundreds of millions of doses of the vaccine candidate...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT